Several U.S. government-funded HIV/AIDS clinical research sites in Africa will join other collaborators in an ongoing clinical trial testing an investigational tuberculosis (TB) vaccine in infants at risk for TB infection. “We are pleased to be able to tap into our existing HIV/AIDS clinical research infrastructure to help test promising investigational vaccines against TB,” said NIAID Director Anthony S. Fauci, M.D. The sites are funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
National Institutes of Health (NIH) News Releases
A new fact sheet from the National Institutes of Health explains the A1C test, a widely used and important test to diagnose type 2 diabetes and prediabetes, and to monitor blood glucose levels of people with type 1 and type 2 diabetes.
National Institutes of Health (NIH) News Releases
Funding for four centers to conduct research on the causes and treatment of learning disabilities in children and adolescents has been provided by the National Institutes of Health.
National Institutes of Health (NIH) News Releases
A clinical trial has shown that addition of chemotherapy to radiation therapy leads to a near doubling of median survival time in patients with a form of brain tumor (oligodendroglioma) that carries a chromosomal abnormality called the 1p19q co-deletion.
National Institutes of Health (NIH) News Releases
Since the discovery of the microscope, scientists have tried to visualize smaller and smaller structures to provide insights into the inner workings of human cells, bacteria and viruses. Now, researchers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, have developed a new way to see structures within viruses that were not clearly seen before.
National Institutes of Health (NIH) News Releases
More than 32 million people in the United States have autoantibodies, which are proteins made by the immune system that target the body’s tissues and define a condition known as autoimmunity, a study shows.
National Institutes of Health (NIH) News Releases
Investigators at the National Institutes of Health have identified a genetic mutation in three unrelated families that causes a rare immune disorder characterized by excessive and impaired immune function. Symptoms of this condition include immune deficiency, autoimmunity, inflammatory skin disorders and cold-induced hives, a condition known as cold urticaria.
The National Institute of General Medical Sciences (NIGMS), a part of the National Institutes of Health that supports basic research and research training, has established two new divisions. Each will administer existing NIGMS programs along with programs transferred to NIGMS from the former NIH National Center for Research Resources (NCRR).
National Institutes of Health (NIH) News Releases
Glaucoma is a major cause of vision loss in the United States, affecting about 2.2 million Americans. The National Eye Institute (NEI) leads research toward better prevention, detection, and treatment of this often silent but devastating disease. During Glaucoma Awareness Month, NEI highlights research advances, showcases education and awareness efforts, and reminds Americans that early detection and treatment is the best way to prevent vision loss.
National Institutes of Health (NIH) News Releases
A new genetics educational program will provide social and behavioral scientists with sufficient genetics background to allow them to engage effectively in interdisciplinary research with genetics researchers. The Office of Behavioral and Social Sciences Research (OBSSR) at the National Institutes of Health, partnered with the National Coalition for Health Professional Education in Genetics to create the free, Web-based project.
National Institutes of Health (NIH) News Releases